ELV Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$449.10median target· current $375.86 (+19.5%)22 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
28 articles · sorted by datePage 1 of 2 · 28 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio16.61Forward 13.97
EPS (TTM)$22.63-13.1% YoY
Profit margin2.5%HEALTHCARE
Market cap$81.51BLarge cap
Valuation
- Forward P/E
- 13.97
- PEG ratio
- 1.33
- P/B
- 1.82
- P/S (TTM)
- 0.41
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 11.1%
- Operating margin
- 4.6%
- Revenue growth YoY
- 1.4%
- Dividend yield
- 1.8%
- Beta
- 0.68
Last earnings
Jul 15, 2026 · Estimate $6.18 · Reported $7.45
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Elevance Health Inc
Company profileElevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Classification
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$81.51B
Shares outstanding$216.9M
52W high$436.24
52W low$268.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent